AR
BHVN

Advisory Research’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Advisory Research’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-7,215
Closed -$855K – 460
2022
Q1 		$855K Sell
7,215
-526
-7% -$62.3K 0.07% 203
2021
Q4 		$1.07M Sell
7,741
-6,324
-45% -$872K 0.08% 191
2021
Q3 		$1.95M Buy
+14,065
New +$1.95M 0.13% 130